SCIEX Expands ZenoTOF Platform with AI and Omics Research Innovations
MARLBOROUGH, Mass., June 1, 2026 SCIEX, a Danaher company and a global leader in life science analytical technologies, announced...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MARLBOROUGH, Mass., June 1, 2026 SCIEX, a Danaher company and a global leader in life science analytical technologies, announced...
PRINCETON, New Jersey, May 26, 2026 Soligenix, Inc. has announced that its proprietary ThermoVax® vaccine platform may provide a...
SUZHOU, China, May 26, 2026 WuXi Vaccines, a wholly owned subsidiary of WuXi Biologics specializing in vaccine Contract Development...
HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 — AGC Biologics...
Paris, France and Cambridge, Massachusetts, USA, May 22, 2026 Nanobiotix, a late-stage clinical biotechnology company specializing in physics-based cancer...
CAMBRIDGE, Mass., May 20, 2026 MetaVia Inc. has announced the publication of new peer-reviewed preclinical research supporting the anti-fibrotic...
HUNTSVILLE, Ala. and KASSEL, Germany, May 20, 2026 Discovery Life Sciences has launched Luminos® Comprehensive, a next-generation IVDR-compliant clinical...
JERUSALEM, Israel, May 20, 2026 Scinai Immunotherapeutics Ltd. has announced the appointment of Eilon Elmalem as the new Site...
INCHEON, South Korea, May 20, 2026 Samsung Bioepis has announced the official launch of Ustekinumab BS 45 mg Syringe...
NEW YORK, May 13, 2026 Nuvation Bio announced a strategic collaboration with Thermo Fisher Scientific to establish U.S.-based manufacturing...
